|
|
| | 6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) Basic information |
| | 6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) Chemical Properties |
| solubility | Soluble to 100 mM in DMSO |
| | 6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) Usage And Synthesis |
| Uses | Senexin A is a useful intermediate. | | in vivo | Senexin A hydrochloride (5 times daily) completely reverses the tumor-promoting effects of chemotherapy. Senexin A hydrochloride had no significant toxicity to body weight, organ weights, or blood cell counts in C57BL/6 mice during treatment. Senexin A hydrochloride treatment significantly improves A549/MEF tumor response to Doxorubicin (HY-15142A)[1]. | | IC 50 | CDK8: 280 nM (IC50); CDK8: 0.83 μM (Kd); CDK19: 0.31 μM (Kd) | | storage | Store at +4°C |
| | 6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]-, hydrochloride (1:1) Preparation Products And Raw materials |
|